Insiders RAPT Therapeutics, Inc.

Equities

RAPT

US75382E1091

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
8.125 ^USD	-0.67%		+2.85%	-67.30%

Apr. 09	RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients	CI
Mar. 27	JPMorgan Lowers RAPT Therapeutics' Price Target to $13 From $15, Keeps Neutral Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RAPT Therapeutics, Inc. Appoints Nipun Davar as Senior Vice President of Technical Operations	Feb. 13	CI
Insider Sell: Rapt Therapeutics	23-03-13	MT
Insider Sell: Rapt Therapeutics	23-01-26	MT
RAPT Therapeutics Announces Executive Changes	22-09-28	CI
RAPT Therapeutics, Inc. Announces Appointment of Gwen Carscadden as Chief Human Resources Officer	22-05-04	CI
RAPT Therapeutics Appoints Lori Lyons-Williams to its Board of Directors	21-11-09	CI
Rapt Therapeutics, Inc. Announces Resignation of Peter Svennilson from Board of Directors	21-07-01	CI
RAPT Therapeutics, Inc. Announces Executive Changes	21-02-04	CI
RAPT Therapeutics, Inc. Appoints Lisa Butterfield and Lawrence Fong to Scientific Advisory Board	20-10-14	CI
RAPT Therapeutics, Inc. Announces Board Changes	20-06-18	CI
RAPT Therapeutics, Inc. Announces Executive Promotions	20-03-04	CI
RAPT Therapeutics, Inc. Appoints Mary Ann Gray to the Board	19-12-05	CI
RAPT Therapeutics, Inc. Appoints Wendye Robbins as Director	19-10-22	CI
RAPT Therapeutics, Inc. Appoints Emma Guttman-Yassky to Scientific Advisory Board	19-07-08	CI
RAPT Therapeutics, Inc. Announces Executive Changes	19-07-08	CI
FLX Bio., Inc. Appoints Michael F. Giordano to its Board of Directors	18-02-05	CI
FLX Bio., Inc. Announces the Phase 1 Clinical Study of CCR4 Antagonist FLX475 to Begin in Late 2017 ; Appoints Scott J. Antonia to Its Scientific Advisory Board	17-09-21	CI
FLX Bio Inc. Announces Appoints to its Scientific Advisory Board	17-05-31	CI
FLX Bio, Inc. Appoints Linda Kozick to its Board of Directors	16-12-12	CI
FLX Bio, Inc. Hires Senior Leaders in Immuno-Oncology Drug Discovery	16-02-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders RAPT Therapeutics, Inc.

Equities

RAPT

US75382E1091

Insiders

Filters